People

Samantha Rothberg

Associate

Rothberg, Sam

Samantha (Sam) Rothberg's practice focuses on all aspects of corporate law. She represents public and private companies in a variety of industries, including technology, life sciences and financial services.

In 2014, Ms. Rothberg was a summer associate at WilmerHale, where she focused on corporate matters. While in law school, Ms. Rothberg researched intellectual property and business strategy in the American fashion industry for Harvard Law School Professor William Fisher and Harvard Business School Professor Felix Oberholzer-Gee. She also researched legal issues relating to open source software licensing for Harvard Law School's Cyberlaw Clinic. Ms. Rothberg was also a legal intern at the General Counsel of the Massachusetts Information Technology Division, where she focused on various legal matters relating to Software-as-a-Service vendor agreements and technology services procurement agreements.

In 2013, Ms. Rothberg was a legal and corporate affairs intern in the Windows Project Group at Microsoft. In that capacity, she analyzed ongoing developments in international copyright and trademark law, and researched domestic and international case law regarding software contracts and licensing.

Previously, Ms. Rothberg was a communications associate at Public Interest GRFX, where she counseled nonprofit clients in the development of a comprehensive communications and outreach strategy.

Publications & News

View

October 17, 2017

WilmerHale Advises Visterra in $46.7M Series C Financing

Visterra, Inc., a clinical-stage biotechnology company that uses its novel Hierotope® platform to identify unique disease targets, announced that it has completed a Series C financing round raising a total of $46.7 million, including a new extension totaling $23.6 million.

July 24, 2017

WilmerHale Represents Trevi Therapeutics in Securing $50M in Series C Financing

The WilmerHale deal team counseling Trevi Therapeutics was led by Stuart Falber and included Sam Rothberg and Cara Fonseca.

July 24, 2017

WilmerHale Reps Emergent BioSolutions in $96M Acquisition of GlaxoSmithKline Anthrax Drug

Emergent BioSolutions announced it would acquire a drug for treating inhaled anthrax from pharmaceutical giant GlaxoSmithKline in an all-cash deal worth up to $96 million.

June 22, 2016

WilmerHale Reps AS&E in $269M Acquisition by OSI Systems

American Science and Engineering, Inc., a leading worldwide supplier of innovative X-ray inspection solutions, announced that it has entered into a definitive agreement to be acquired by OSI Systems, Inc. for a total transaction value of approximately $269 million.

March 24, 2016

2016 M&A Report

Our 2016 M&A Report offers a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions; updates on takeover defenses and public company deal litigation; practical guidance on avoiding antitrust violations in pre-merger integration planning; a look at what buyers need to know about appraisal claims in private company mergers; and a survey of key terms and issues in sales of VC-backed companies.

Practices

Skip Navigation Links.

Education

JD, cum laude, Harvard Law School, 2015, Article Editor, Journal of Law and Technology

BA, History, minor in Sustainable Development, Columbia University, 2009

Bar Admissions

Massachusetts

Skip Navigation Links.